SEC Form 4 · accession 0001061983-17-000056
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Caryn Gordon McDowell
Officer — GC & Chief Compliance Officer
Period of report
Sep 6, 2017
Accepted (ET)
Sep 8, 2017 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 6, 2017 | M | 1,432 | $6.67 | A | 19,801 | D | |
| Common Stock | Sep 6, 2017 | S | 200 | $14.10 | D | 19,601 | D | |
| Common Stock | Sep 6, 2017 | M | 3,067 | $6.67 | A | 22,668 | D | |
| Common Stock | Sep 6, 2017 | S | 200 | $14.15 | D | 22,468 | D | |
| Common Stock | Sep 6, 2017 | M | 5,732 | $6.37 | A | 28,200 | D | |
| Common Stock | Sep 6, 2017 | S | 898 | $14.20 | D | 27,302 | D | |
| Common Stock | Sep 6, 2017 | S | 400 | $14.25 | D | 26,902 | D | |
| Common Stock | Sep 6, 2017 | S | 100 | $14.275 | D | 26,802 | D | |
| Common Stock | Sep 6, 2017 | S | 302 | $14.30 | D | 26,500 | D | |
| Common Stock | Sep 6, 2017 | S | 200 | $14.35 | D | 26,300 | D | |
| Common Stock | Sep 6, 2017 | S | 200 | $14.375 | D | 26,100 | D | |
| Common Stock | Sep 6, 2017 | S | 400 | $14.40 | D | 25,700 | D | |
| Common Stock | Sep 6, 2017 | S | 600 | $14.45 | D | 25,100 | D | |
| Common Stock | Sep 6, 2017 | S | 200 | $14.475 | D | 24,900 | D | |
| Common Stock | Sep 6, 2017 | S | 200 | $14.50 | D | 24,700 | D | |
| Common Stock | Sep 6, 2017 | S | 200 | $14.525 | D | 24,500 | D | |
| Common Stock | Sep 6, 2017 | S | 200 | $14.575 | D | 24,300 | D | |
| Common Stock | Sep 6, 2017 | S | 700 | $14.60 | D | 23,600 | D | |
| Common Stock | Sep 6, 2017 | S | 300 | $14.625 | D | 23,300 | D | |
| Common Stock | Sep 6, 2017 | S | 200 | $14.65 | D | 23,100 | D | |
| Common Stock | Sep 6, 2017 | S | 500 | $14.70 | D | 22,600 | D | |
| Common Stock | Sep 6, 2017 | S | 200 | $14.725 | D | 22,400 | D | |
| Common Stock | Sep 6, 2017 | S | 600 | $14.75 | D | 21,800 | D | |
| Common Stock | Sep 6, 2017 | S | 400 | $14.775 | D | 21,400 | D | |
| Common Stock | Sep 6, 2017 | S | 400 | $14.80 | D | 21,000 | D | |
| Common Stock | Sep 6, 2017 | S | 100 | $14.825 | D | 20,900 | D | |
| Common Stock | Sep 6, 2017 | S | 724 | $14.85 | D | 20,176 | D | |
| Common Stock | Sep 6, 2017 | S | 600 | $14.90 | D | 19,576 | D | |
| Common Stock | Sep 6, 2017 | S | 400 | $14.925 | D | 19,176 | D | |
| Common Stock | Sep 6, 2017 | S | 707 | $14.95 | D | 18,469 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.